Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.
$143.52
FY2025 · ▲ $19.61 vs FY2024
| Fiscal year | Year end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price, by fiscal year |
|---|---|---|
| FY2025 | Dec 31, 2025 | $143.52 |
| FY2024 | Dec 31, 2024 | $123.91 |
| FY2023 | Dec 31, 2023 | $166.62 |
| FY2022 | Dec 31, 2022 | $176.21 |
| FY2021 | Dec 31, 2021 | $182.63 |
| FY2020 | Dec 31, 2020 | $181.33 |
| FY2019 | Dec 31, 2019 | $201.27 |
| Period | Length | Value | Last reported | Filings |
|---|---|---|---|---|
| Jan 1, 2025 – Dec 31, 2025 | Year | $143.52 | Feb 3, 2026 | 1 |
| Jan 1, 2024 – Dec 31, 2024 | Year | $123.91 | Feb 5, 2025 | 1 |
| Jan 1, 2023 – Dec 31, 2023 | Year | $166.62 | Feb 7, 2024 | 1 |
| Jan 1, 2022 – Dec 31, 2022 | Year | $176.21 | Feb 8, 2023 | 1 |
| Jan 1, 2022 – Sep 30, 2022 | 9 months | $178.08 | Oct 25, 2022 | 1 |
| Jan 1, 2022 – Jun 30, 2022 | 6 months | $179.40 | Jul 27, 2022 | 1 |
| Jan 1, 2022 – Mar 31, 2022 | Quarter | $174.36 | Apr 26, 2022 | 1 |
| Jan 1, 2021 – Dec 31, 2021 | Year | $182.63 | Feb 8, 2023 | 3 |
| Jan 1, 2021 – Sep 30, 2021 | 9 months | $179.50 | Oct 26, 2021 | 1 |
| Jan 1, 2020 – Dec 31, 2020 | Year | $181.33 | Feb 8, 2023 | 3 |
| Jan 1, 2019 – Dec 31, 2019 | Year | $201.27 | Apr 26, 2022 | 2 |